Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Cutaneous tolerability and therapeutic benefits of LAS-41010

Oct. 15, 2014

In vitro inhibition of Middle East respiratory syndrome coronavirus with BanLec

Oct. 15, 2014

Promising results presented for the novel EGFR tyrosine kinase inhibitor, AZD-9291

Oct. 15, 2014

RAPID-PsA phase III results for certolizumab pegol in patients with active psoriasis

Oct. 15, 2014

Phase II results for field-mixed avian influenza A/H7N9 vaccine with MF59 adjuvant

Oct. 15, 2014

Novel anti-EGFR repebody for the detection and treatment of EGFR-expressing tumors

Oct. 14, 2014

Safety and pharmacokinetic analysis of N-91115 supports once-daily dosing

Oct. 14, 2014

Phase IIb data for dupilumab in patients with atopic dermatitis reported

Oct. 14, 2014

SYN-004, a novel, potent beta-lactamase, protects intestinal microflora in vivo

Oct. 14, 2014

Double transgenic mouse model of MS used to assess ATX-MS-1467 effects

Oct. 14, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...